Literature DB >> 22188086

Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan.

Yi-Ming Chen, Der-Yuan Chen, Liang-Kung Chen, Yi-Wen Tsai, Li-Chuan Chang, Weng-Foung Huang, Liang-Kung Chen, Chien-Liang Liu, Yi-Tsun Chen, Fei-Yuan Hsiao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22188086     DOI： 10.1111/j.1532-5415.2011.03693.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  9 in total

1.  Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.

Authors:  K Sun; J M Liu; H X Sun; N Lu; G Ning
Journal:  Osteoporos Int       Date:  2012-10-06       Impact factor: 4.507

2.  Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study.

Authors:  F Y Hsiao; W W Y Hsu
Journal:  Int Urol Nephrol       Date:  2013-09-06       Impact factor: 2.370

3.  Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study.

Authors:  Fei-Yuan Hsiao; Pei-Hua Hsieh; Weng-Foung Huang; Yi-Wen Tsai; Churn-Shiouh Gau
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

4.  Care needs and clinical outcomes of older people with dementia: a population-based propensity score-matched cohort study.

Authors:  Fei-Yuan Hsiao; Li-Ning Peng; Yu-Wen Wen; Chih-Kuang Liang; Pei-Ning Wang; Liang-Kung Chen
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

Review 5.  The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies.

Authors:  Ling-Xiao Chen; Guang-Zhi Ning; Zhi-Rui Zhou; Yu-Lin Li; Di Zhang; Qiu-Li Wu; Tian-Song Zhang; Lei Cheng; Shi-Qing Feng
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

6.  Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).

Authors:  Ellen Wright; Peter T Schofield; Paul Seed; Mariam Molokhia
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

7.  Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.

Authors:  Emily Vogtmann; Douglas A Corley; Lucy M Almers; Chris R Cardwell; Liam J Murray; Christian C Abnet
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 8.  Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.

Authors:  Ellen Wright; Peter T Schofield; Mariam Molokhia
Journal:  BMJ Open       Date:  2015-12-07       Impact factor: 2.692

9.  Bisphosphonates and risk of cancers: a systematic review and meta-analysis.

Authors:  Yu-Peng Liu; Cun-Xian Jia; Yuan-Yuan Li; Li-Jie Gao; Yu-Xue Zhang; Shu-Juan Liu; Shuo Cheng
Journal:  Br J Cancer       Date:  2020-09-09       Impact factor: 9.075
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.